Type I Error can have significant consequences in cancer diagnosis. A false positive result can lead to unnecessary emotional distress for the patient, as well as additional and often invasive diagnostic procedures. It can also result in an increase in healthcare costs and potential exposure to harmful treatments such as chemotherapy or radiation therapy that are not needed.
